Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
6.01
-0.28 (-4.45%)
At close: Apr 1, 2025, 4:00 PM
6.03
+0.02 (0.27%)
After-hours: Apr 1, 2025, 4:25 PM EDT

Trevi Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2016
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2016
Net Income
-47.91-29.07-29.15-33.94-32.76
Upgrade
Depreciation & Amortization
0.150.120.040.050.05
Upgrade
Other Amortization
-0.570.520.60.23
Upgrade
Loss (Gain) From Sale of Assets
-0.01---
Upgrade
Loss (Gain) From Sale of Investments
-1.37-2.13-0.83--
Upgrade
Stock-Based Compensation
3.592.252.332.542.42
Upgrade
Other Operating Activities
0.460.380.150.290.01
Upgrade
Change in Accounts Payable
1.61-1.050.010.830.42
Upgrade
Change in Other Net Operating Assets
5.22-2.8-1.240.680.64
Upgrade
Operating Cash Flow
-38.26-31.71-28.18-28.95-29
Upgrade
Capital Expenditures
-0.04-0.14-0.16--0.03
Upgrade
Investment in Securities
-21.4959.57-107.21--
Upgrade
Investing Cash Flow
-21.5359.43-107.37--0.03
Upgrade
Long-Term Debt Issued
----14
Upgrade
Long-Term Debt Repaid
-0.13-9.5-5.83--
Upgrade
Net Debt Issued (Repaid)
-0.13-9.5-5.83-14
Upgrade
Issuance of Common Stock
61.611.85117.4321.233.18
Upgrade
Other Financing Activities
--0.26-0.29-0.45-0.46
Upgrade
Financing Cash Flow
61.48-7.91111.3120.7816.72
Upgrade
Net Cash Flow
1.719.81-24.24-8.17-12.31
Upgrade
Free Cash Flow
-38.29-31.85-28.33-28.95-29.03
Upgrade
Free Cash Flow Per Share
-0.38-0.32-0.44-1.27-1.61
Upgrade
Cash Interest Paid
00.330.590.60.18
Upgrade
Levered Free Cash Flow
-21.03-21.97-17.95-16.5-16.62
Upgrade
Unlevered Free Cash Flow
-21.03-22.3-17.74-16.35-16.56
Upgrade
Change in Net Working Capital
-7.483.331.26-1.36-1.31
Upgrade
Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q